---
title: "Carboplatin Injection Shortage: Supply Updates and Manufacturer Availability"
summary: "Carboplatin Injection, a critical oncology medication, is currently facing supply challenges with several manufacturers reporting limited availability, backorders, or discontinuations."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Carboplatin","Injection"]
location: "United States"
severity: "high"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:40:26.000Z
---
### What's in Shortage
Carboplatin Injection (brand name: CARBOPLATIN) is currently listed as being in shortage. This medication is classified under the oncology therapeutic category and is provided in an injection dosage form. The shortage status is currently active, having been first posted on April 28, 2023, and most recently updated on February 2, 2026.

### Which Manufacturers Are Affected
Several manufacturers are reporting varying levels of availability for Carboplatin Injection:

*   **Teva Pharmaceuticals USA, Inc. (800-545-8800):** 
    *   Limited Availability: 10 mg/1 mL (NDC 0703-4239-01) with an estimated recovery date of June 2026.
    *   Available: Multiple presentations (NDC 0703-4244-01, 0703-4246-01, 0703-4248-01).
*   **Accord Healthcare Inc. (866-941-7875, option 2):** 
    *   Unavailable: Multiple presentations (NDC 16729-295-12, 16729-295-34).
    *   Discontinued: The manufacture of certain presentations has been discontinued (NDC 16729-295-31, 16729-295-33).
*   **Eugia US LLC (888-238-7880):** 
    *   Unavailable: 450 mg/45 mL (NDC 55150-335-01) is on backorder with recovery TBD. Patients and providers are advised to check wholesalers for inventory.
    *   Available: 600 mg/60 mL (NDC 55150-386-01).
*   **Fresenius Kabi USA, LLC (888-386-1300):** 
    *   Available: 10 mg/1 mL (NDC 63323-172-60). Providers should check wholesalers for current inventory.

### Why There's a Shortage
The reason for the shortage of Carboplatin Injection is officially listed as "Other." No further specific details regarding the cause of the supply disruption were provided in the official report.

### What Patients Should Do
Patients who rely on Carboplatin for their treatment should be aware that while some presentations are available, others are currently difficult to source. 

*   **Consult Your Healthcare Provider:** It is essential to speak with your oncologist or healthcare team regarding your treatment plan and how this shortage may affect your care.
*   **Speak with Your Pharmacist:** Pharmacists may have the most up-to-date information on local inventory and wholesaler availability.
*   **Contact Manufacturers:** If you have specific questions about a particular presentation, you may use the contact information provided above.

**Disclaimer:** This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist for medical advice and treatment options.

### Source
Information provided by the FDA Drug Shortage Database.